European expert panel consensus on the clinical management of BRAF-mutant metastatic colorectal cancer
Erika Martinelli, Dirk Arnold, Andrés Cervantes, Sebastian Stintzing, Eric Van Cutsem, Josep Tabernero, Julien Taı̈eb, Harpreet Wasan, Fortunato Ciardiello
Abstract
-mutant mCRC and define priorities for the development of novel therapeutic strategies that are needed to improve patient outcomes.
Topics & Concepts
KRASMedicineNeuroblastoma RAS viral oncogene homologColorectal cancerTargeted therapyOncologyInternal medicineCancerBioinformaticsBiologyColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerCancer Genomics and Diagnostics